This website uses cookies to enhance the user experience.
||
M

MYCOTECH PHARMA AS928 974 847

Limited company
Mustads vei 1A 0283 OSLO, Norge

MYCOTECH PHARMA AS

Organization

Chairman of the board
Years since formation
3 years
since Mar 23, 2022
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
112,841,220
1 share class
Total number of shareholders
11
8 companies, 3 persons
Belongs to group of

Financials

Total operating income 2024
3,526,886
NOK
Annual total result 2024
-24,831,895
NOK
Total equity 2024
20,157,325
NOK
Last update: Sep 9, 2025

Management

Board

NameRoleShares
Board Member-
Chairman
1.21 %
indirectly

Others

NameRoleShares
F
FORVIS MAZARS AS
Auditor-

Top 10 individual shareholders

NameRoleShares
-
35.34 %
indirectly
-
23.73 %
indirectly
-
1.57 %
indirectly
-
1.41 %
indirectly
Chairman
1.21 %
indirectly
Last update: Jul 1, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
I
IMMUNOPHARMA AS
Ordinary shares
110,330,000
97.77 %
N
NICOLINE INVEST AS
Ordinary shares
770,000
0.68 %
B
BOHAN & CO AS
Ordinary shares
770,000
0.68 %
P
PVO INVEST AS
Ordinary shares
256,410
0.23 %
C
CINCO INVEST AS
Ordinary shares
165,000
0.15 %
J
Ordinary shares
165,000
0.15 %
Ordinary shares
128,205
0.11 %
Ordinary shares
110,000
0.1 %
Ordinary shares
64,105
0.06 %
L
LANDMARK INVEST AS
Ordinary shares
55,000
0.05 %
3
3LP NORGE AS
Ordinary shares
27,500
0.02 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 12,205,647,000
    Operating profit 2024: NOK -38,517,269,000
    Employees: 9

Financials

in NOK

Summary

Year202420232022
Total operating income
3,526,886
2,033,410
1,195,897
Annual Total Result
-24,831,895
-18,750,918
-11,398,297
Total assets
55,199,187
67,273,250
41,953,878
Total liabilities
35,041,862
52,203,859
33,533,996
Total equity
20,157,325
15,069,392
8,419,883

P&L

Year202420232022
Total operating income
3,526,886
2,033,410
1,195,897
Total operating costs
33,093,962
26,504,833
11,895,817
Operating result
-29,567,077
-24,471,423
-10,699,919
Financial income/costs
-901,411
-1,443,718
-698,378
Profit before tax
-30,468,488
-25,915,141
-11,398,297
Total tax & extraordinary income/cost
-5,636,593
-7,164,223
0
Annual Total Result
-24,831,895
-18,750,918
-11,398,297

Balance overview

Year202420232022
Total fixed assets
22,728,711
29,319,659
36,430,906
Total current assets
32,470,475
37,953,591
5,522,972
Total assets
55,199,187
67,273,250
41,953,878
Short term debt
8,060,490
4,846,464
1,811,996
Long term debt
26,981,372
47,357,394
31,722,000
Total liabilities
35,041,862
52,203,859
33,533,996
Contributed capital
20,157,325
15,069,392
10,258,293
Retained earnings
0
0
-1,838,410
Total equity
20,157,325
15,069,392
8,419,883
Total equity and liabilities
55,199,187
67,273,250
41,953,878

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises